Pharmacological Treatment for Social Cognition: Current Evidence.

Animals Antipsychotic Agents / therapeutic use Cognition / drug effects Humans Social Cognition
antipsychotic pharmacological treatment schizophrenia social cognition

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
12 Jul 2021
Historique:
received: 29 04 2021
revised: 28 06 2021
accepted: 06 07 2021
entrez: 24 7 2021
pubmed: 25 7 2021
medline: 31 7 2021
Statut: epublish

Résumé

Cognitive impairment is currently considered a core feature of schizophrenia (SZ) and is gaining attention as a fundamental therapeutic target. Standard treatment for SZ involves the use of antipsychotics that are successfully used to control positive symptoms and disorganized behaviour. However, it is still unclear whether they are effective on social cognition (SC) impairment. Furthermore, different medications are currently being studied to improve SC in patients with SZ. A literature search on this topic was conducted using the PubMed database. All kinds of publications (i.e., reviews, original contributions and case reports) written in English and published in the last 15 years were included. The aim of our literature review is to draw a picture of the current state of the pharmacological treatment of SC impairment in SZ.

Identifiants

DOI: 10.3390/ijms22147457 PMID: 34299076 PMC: PMC8307511
pubmed: 34299076
pii: ijms22147457
doi: 10.3390/ijms22147457
pmc: PMC8307511
pii:
doi:

Substances chimiques

Antipsychotic Agents 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

Psychiatry Res. 2002 Mar 15;109(2):149-59
pubmed: 11927140
Schizophr Bull. 2018 Jun 6;44(4):737-748
pubmed: 28981848
Mol Psychiatry. 2015 Jun;20(6):685-94
pubmed: 25980345
Harv Rev Psychiatry. 2013 Sep-Oct;21(5):219-47
pubmed: 24651556
Pharmaceuticals (Basel). 2021 Mar 09;14(3):
pubmed: 33803277
Front Hum Neurosci. 2015 Mar 17;9:132
pubmed: 25852519
Dev Psychopathol. 2014 Feb;26(1):33-40
pubmed: 24059811
CNS Drugs. 2016 Mar;30(3):193-208
pubmed: 26895254
Schizophr Res. 2015 Nov;168(3):628-33
pubmed: 26150070
Schizophr Bull. 2005 Jan;31(1):21-42
pubmed: 15888423
Curr Top Behav Neurosci. 2018;35:3-29
pubmed: 28812263
Schizophr Res. 2010 Sep;122(1-3):164-71
pubmed: 20400268
Schizophr Bull. 2017 Oct 21;43(6):1240-1250
pubmed: 28575475
Arch Gen Psychiatry. 2004 Sep;61(9):866-76
pubmed: 15351765
J Abnorm Psychol. 1994 May;103(2):371-8
pubmed: 8040506
Psychol Bull. 2021 Mar;147(3):293-327
pubmed: 33151703
Schizophr Bull. 1999;25(4):677-92
pubmed: 10667739
Horm Behav. 2013 Sep;64(4):693-701
pubmed: 24055336
Neuropsychologia. 2010 Apr;48(5):1209-15
pubmed: 20026084
Nat Rev Neurosci. 2008 Apr;9(4):267-77
pubmed: 18354399
J Neurosci Methods. 2002 Apr 15;115(2):137-43
pubmed: 11992665
Schizophr Bull. 2012 Mar;38(2):304-15
pubmed: 20624752
Cognition. 2008 Sep;108(3):771-80
pubmed: 18692779
Biol Psychiatry. 2016 Feb 1;79(3):234-42
pubmed: 26257243
Schizophr Res. 2007 Feb;90(1-3):316-24
pubmed: 17141477
Clin Psychol Rev. 2016 Dec;50:108-137
pubmed: 27771557
Psychol Med. 2007 Apr;37(4):595-601
pubmed: 17094815
Biol Psychiatry. 2011 Mar 1;69(5):442-9
pubmed: 21145041
Annu Rev Med. 2001;52:503-17
pubmed: 11160792
Neurosci Biobehav Rev. 2015 Apr;51:263-75
pubmed: 25660957
Schizophr Bull. 2008 Nov;34(6):1211-20
pubmed: 18184635
Schizophr Bull. 2009 Jan;35(1):153-62
pubmed: 19011231
J Abnorm Psychol. 1993 May;102(2):312-8
pubmed: 8315144
PLoS One. 2011;6(10):e25322
pubmed: 21998649
Schizophr Bull. 2012 Jun;38(4):854-64
pubmed: 21345917
Neuropsychopharmacology. 2003 Jan;28(1):193-8
pubmed: 12496956
Biol Psychiatry. 2013 Aug 1;74(3):180-8
pubmed: 23079235
Schizophr Res. 2008 Mar;100(1-3):237-41
pubmed: 18255273
Psychiatry Res. 2004 Sep 30;128(2):155-65
pubmed: 15488958
Schizophr Res. 2004 Feb 1;66(2-3):201-2
pubmed: 15061258
CNS Drugs. 2013 May;27(5):335-43
pubmed: 23533009
Am J Psychiatry. 2006 Mar;163(3):418-25
pubmed: 16513862
Schizophr Bull. 2013 Jan;39(1):102-11
pubmed: 21765165
Eur Neuropsychopharmacol. 2014 Apr;24(4):575-84
pubmed: 24418213
J Neurosci. 2009 Feb 18;29(7):2259-71
pubmed: 19228979
Schizophr Bull. 2015 Mar;41(2):483-93
pubmed: 24962607
Schizophr Bull. 1999;25(4):693-708
pubmed: 10667740
Schizophr Res. 1995 Sep;17(1):5-13
pubmed: 8541250
Schizophr Bull. 2011 Sep;37 Suppl 2:S41-54
pubmed: 21860046
Clin Neuropharmacol. 2005 Sep-Oct;28(5):228-37
pubmed: 16239763
Front Psychiatry. 2018 Apr 24;9:157
pubmed: 29740360
Schizophr Bull. 2000;26(1):119-36
pubmed: 10755673
Schizophr Res. 2009 Sep;113(2-3):189-99
pubmed: 19628375
Clin Psychol Rev. 2012 Dec;32(8):724-40
pubmed: 23059624
CNS Spectr. 2004 May;9(5):335-43
pubmed: 15115945
Psychiatry Res. 2009 Jun 30;172(3):180-3
pubmed: 19386475
J Nerv Ment Dis. 2020 Sep;208(9):701-705
pubmed: 32433201
Psychol Med. 2016 Oct;46(13):2717-29
pubmed: 27649341
Curr Top Behav Neurosci. 2018;35:31-53
pubmed: 28864972
Cortex. 2020 Sep;130:142-157
pubmed: 32653744
Biol Psychiatry. 2000 Jul 15;48(2):127-36
pubmed: 10903409
Schizophr Bull. 2011 Sep;37 Suppl 2:S71-9
pubmed: 21860050
Transl Psychiatry. 2016 May 03;6:e795
pubmed: 27138794
Nature. 2013 Sep 12;501(7466):179-84
pubmed: 24025838
Proc Natl Acad Sci U S A. 1992 Jul 1;89(13):5981-5
pubmed: 1321430
Schizophr Bull. 2006 Oct;32 Suppl 1:S81-93
pubmed: 16916888
Biol Psychiatry. 2012 Jan 15;71(2):136-45
pubmed: 21993193
Curr Top Med Chem. 2016;16(29):3385-3403
pubmed: 27291902
Schizophr Bull. 2010 Sep;36(5):1009-19
pubmed: 19329561
Psychiatry Clin Neurosci. 2014 Sep;68(9):701-11
pubmed: 24612235
Biol Psychiatry. 2003 Dec 15;54(12):1389-98
pubmed: 14675803
Neurobiol Dis. 2019 Nov;131:104315
pubmed: 30391541
Psychiatry Res. 1997 Jul 4;71(2):105-13
pubmed: 9255855
Curr Opin Neurobiol. 2001 Apr;11(2):231-9
pubmed: 11301245
Psychiatry Res. 2010 Jun 30;178(1):46-50
pubmed: 20452678
Clin Psychopharmacol Neurosci. 2018 Feb 28;16(1):18-31
pubmed: 29397663
Schizophr Res. 2008 Jan;98(1-3):247-55
pubmed: 17961988
Curr Top Behav Neurosci. 2018;35:321-348
pubmed: 28864976
Novartis Found Symp. 2006;270:129-40; discussion 140-5, 164-9
pubmed: 16649712
Psychiatry Res. 2006 Dec 1;148(2-3):75-92
pubmed: 17088049
Schizophr Bull. 2007 Jul;33(4):912-20
pubmed: 17567627
Am J Psychiatry. 2010 Feb;167(2):160-9
pubmed: 20048021
J Clin Exp Neuropsychol. 2006 Feb;28(2):193-207
pubmed: 16484093
Annu Rev Neurosci. 2004;27:169-92
pubmed: 15217330
Schizophr Res. 2015 Nov;168(3):614-27
pubmed: 26123171
Am J Psychiatry. 2014 Sep;171(9):969-78
pubmed: 24874453
Schizophr Bull. 2017 Oct 21;43(6):1291-1303
pubmed: 28586471
Schizophr Res. 1992 Dec;8(2):129-35
pubmed: 1457391
Psychiatry Res. 2018 Dec;270:459-466
pubmed: 30551311
World Psychiatry. 2019 Jun;18(2):146-161
pubmed: 31059632
Schizophr Bull. 2005 Oct;31(4):882-7
pubmed: 16135561
Neuroendocrinology. 2002 Oct;76(4):214-22
pubmed: 12411738
J Clin Psychiatry. 2006;67 Suppl 9:3-8; discussion 36-42
pubmed: 16965182
Biol Psychiatry. 2004 Sep 1;56(5):301-7
pubmed: 15336511
World Psychiatry. 2014 Oct;13(3):275-87
pubmed: 25273301
Neurosci Biobehav Rev. 2019 Feb;97:10-33
pubmed: 30244163
Asian J Psychiatr. 2018 Jun;35:115-131
pubmed: 27670776
Neurosci Biobehav Rev. 2011 Jan;35(3):573-88
pubmed: 20620163
Eur Neuropsychopharmacol. 2016 Oct;26(10):1619-28
pubmed: 27527256
J Child Psychol Psychiatry. 2001 Feb;42(2):241-51
pubmed: 11280420
Schizophr Bull. 2003;29(3):487-97
pubmed: 14609242
Psychoneuroendocrinology. 1985;10(2):187-91
pubmed: 4034849
Schizophr Res. 2013 Jul;147(2-3):393-7
pubmed: 23676253
Psychol Med. 1996 May;26(3):521-30
pubmed: 8733211
Schizophr Res. 2009 Aug;113(1):72-6
pubmed: 19545977
Schizophr Bull. 2007 Sep;33(5):1247-56
pubmed: 17255120
Curr Top Behav Neurosci. 2018;35:155-173
pubmed: 28864973
Schizophr Res. 2016 Nov;177(1-3):59-66
pubmed: 27132494
Biol Psychiatry Cogn Neurosci Neuroimaging. 2016 Mar 1;1(2):141-151
pubmed: 26977453
Clin Psychol Rev. 2016 Feb;43:80-9
pubmed: 26437567
J Psychiatr Res. 2020 Jan;120:163-174
pubmed: 31689587
Rev Colomb Psiquiatr (Engl Ed). 2018 Jul - Sep;47(3):170-176
pubmed: 30017040
Schizophr Bull. 2014 Jul;40(4):813-23
pubmed: 23728248
CNS Drugs. 2020 Sep;34(9):947-959
pubmed: 32783116
Disabil Rehabil. 2006 Dec 30;28(24):1529-42
pubmed: 17178616
Front Hum Neurosci. 2015 Jan 23;9:9
pubmed: 25667571
Ital J Anat Embryol. 1995 Oct-Dec;100(4):189-93
pubmed: 8826796
Am J Psychiatry. 2011 May;168(5):472-85
pubmed: 21406461
Biol Psychiatry. 2007 Feb 15;61(4):498-503
pubmed: 16904652
Schizophr Bull. 2013 Sep;39(5):979-92
pubmed: 22949733
Front Neuroendocrinol. 2016 Jan;40:1-23
pubmed: 25951955
Schizophr Res. 2019 Jan;203:3-11
pubmed: 28712968
Nature. 2015 Apr 23;520(7548):499-504
pubmed: 25874674
Psychol Med. 2002 Oct;32(7):1273-84
pubmed: 12420896
Nat Rev Neurosci. 2015 Oct;16(10):620-31
pubmed: 26373471
Schizophr Res. 2008 Oct;105(1-3):125-37
pubmed: 18722092
Schizophr Res. 2013 Mar;144(1-3):31-6
pubmed: 23347949
Neuropsychopharmacology. 2014 Aug;39(9):2070-7
pubmed: 24637803
Neuropsychobiology. 2016;73(1):35-42
pubmed: 26812618

Auteurs

Cecilia Riccardi (C)

Department of Neuroscience "Rita Levi Montalcini", University of Turin, 10100 Turin, Italy.

Cristiana Montemagni (C)

Department of Neuroscience "Rita Levi Montalcini", University of Turin, 10100 Turin, Italy.

Elisa Del Favero (E)

Department of Neuroscience "Rita Levi Montalcini", University of Turin, 10100 Turin, Italy.

Silvio Bellino (S)

Department of Neuroscience "Rita Levi Montalcini", University of Turin, 10100 Turin, Italy.
ORCID: 0000-0002-6555-8000

Claudio Brasso (C)

Department of Neuroscience "Rita Levi Montalcini", University of Turin, 10100 Turin, Italy.

Paola Rocca (P)

Department of Neuroscience "Rita Levi Montalcini", University of Turin, 10100 Turin, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Pharmacological Treatment for Social...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Agents du système nerveux central › Psychoanaleptiques › Tranquillisants › Neuroleptiques › Pharmacological Treatment for Social...
questionsmedicales.fr › Phénomènes psychologiques › Processus mentaux › Cognition › Pharmacological Treatment for Social...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Pharmacological Treatment for Social...
questionsmedicales.fr › Phénomènes psychologiques › Processus mentaux › Perception › Perception sociale › Cognition sociale › Pharmacological Treatment for Social...